BR1100487A - Processo para a preparação de pelotas e medicamentos para a administração oral - Google Patents

Processo para a preparação de pelotas e medicamentos para a administração oral

Info

Publication number
BR1100487A
BR1100487A BR1100487-8A BR1100487A BR1100487A BR 1100487 A BR1100487 A BR 1100487A BR 1100487 A BR1100487 A BR 1100487A BR 1100487 A BR1100487 A BR 1100487A
Authority
BR
Brazil
Prior art keywords
water
pellets
xanthine derivative
anhydrous
particle size
Prior art date
Application number
BR1100487-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Thomas Moest
Claus Hinrich Pich
Original Assignee
Thomas Moest
Claus Hinrich Pich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Moest, Claus Hinrich Pich filed Critical Thomas Moest
Publication of BR1100487A publication Critical patent/BR1100487A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BR1100487-8A 1989-09-08 1997-05-13 Processo para a preparação de pelotas e medicamentos para a administração oral BR1100487A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3929864A DE3929864A1 (de) 1989-09-08 1989-09-08 Verfahren zur herstellung von theophyllin-pellets

Publications (1)

Publication Number Publication Date
BR1100487A true BR1100487A (pt) 1999-12-07

Family

ID=6388901

Family Applications (1)

Application Number Title Priority Date Filing Date
BR1100487-8A BR1100487A (pt) 1989-09-08 1997-05-13 Processo para a preparação de pelotas e medicamentos para a administração oral

Country Status (11)

Country Link
US (1) US5160469A (enExample)
EP (1) EP0418600B1 (enExample)
JP (1) JP2996702B2 (enExample)
AT (1) ATE78400T1 (enExample)
BR (1) BR1100487A (enExample)
CA (1) CA2024863C (enExample)
DE (2) DE3929864A1 (enExample)
DK (1) DK0418600T3 (enExample)
ES (1) ES2034805T3 (enExample)
GR (1) GR3005944T3 (enExample)
HU (1) HU211657A9 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69311394T2 (de) * 1992-02-20 1997-10-30 Euro Celtique Sa Arzneimittel verzögerter Wirkstoffabgabe
DE4231493A1 (de) * 1992-09-21 1994-03-24 Nordmark Arzneimittel Gmbh Verfahren zur Herstellung von Pellets aus einem Ephedrinderivat
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
CN106748584B (zh) * 2016-11-29 2019-03-19 西南科技大学 乳液法制备球形化有机小分子复合物的方法
CA3223776A1 (en) * 2021-07-09 2023-01-12 Evonik Operations Gmbh Hard shell capsules having improved colon release

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
CA1066029A (en) * 1973-03-16 1979-11-13 Alberto Rabassa Process for the preparation of non-dusty, easily wetted and readily soluble granulates
JPS55153715A (en) * 1979-05-18 1980-11-29 Nikken Kagaku Kk Prolonged granule of theophylline
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
DE3324115A1 (de) * 1983-07-05 1985-01-17 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
IE58246B1 (en) * 1984-12-21 1993-08-11 Byk Gulden Lomberg Chem Fab Theophylline sustained release formulation
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
DE3712058A1 (de) * 1987-04-09 1988-10-20 Boehringer Ingelheim Kg Theophyllinhaltige pharmazeutische formen
US4786509A (en) * 1987-05-18 1988-11-22 Schering Corporation Dry sustained release theophylline oral formulation
HU198933B (en) * 1987-11-02 1989-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing new xanthine derivatives and pharmaceutical compositions comprising same as active ingredient

Also Published As

Publication number Publication date
EP0418600A1 (de) 1991-03-27
CA2024863C (en) 2001-11-27
US5160469A (en) 1992-11-03
GR3005944T3 (enExample) 1993-06-07
CA2024863A1 (en) 1991-03-09
ES2034805T3 (es) 1993-04-01
ATE78400T1 (de) 1992-08-15
HU211657A9 (en) 1995-12-28
JPH03167124A (ja) 1991-07-19
EP0418600B1 (de) 1992-07-22
DE3929864A1 (de) 1991-03-14
DE59000215D1 (de) 1992-08-27
DK0418600T3 (da) 1992-08-31
JP2996702B2 (ja) 2000-01-11

Similar Documents

Publication Publication Date Title
JP3667778B2 (ja) スフェロイド製剤
KR0136279B1 (ko) 일정수분을 함유하는 서방형 제제
US5858411A (en) Sustained-release granular preparations and production process thereof
IT1216570B (it) Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
ZA200005915B (en) Pharmaceutical compositions capable of being gelled.
KR880004805A (ko) 분무건조된 아세트아미노펜
EP0285682A1 (en) Process for the manufacture of vitamin preparations
IL103005A0 (en) Process for producing pharmaceutical compositions
US5322698A (en) Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure
JPS58185578A (ja) 新規結晶形の（＋）―カテキン１水和物，その製造方法及びそれを含有する固形製剤
PT96229A (pt) Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico
ES2034805T3 (es) Procedimiento para la obtencion de pellets de derivados de xantina.
ES2090802T3 (es) Procedimiento para la obtencion de pellets de un derivado de efedrina.
JPS61151133A (ja) 遅延放出性被覆組成物及びこれにより被覆した被覆製剤
JPS5726615A (en) Improving method for absorbability of slightly soluble drug
CN108785272A (zh) 一种奥利司他软胶囊及其制备方法
RS50433B (sr) Postupak za dobijanje i upotreba sfernih klastera telitromicina za pripremanje farmaceutskih oblika
GOTO et al. Preparation and evaluation of gelatin microcapsules of sulfonamides
HU203477B (en) Process for producing antiflatulant pharmaceutical compositions containing activated poly-dimethyl-siloxane in form of solide dispersion
DK1381285T3 (da) Rumen-bypass-sammensætning indeholdende bioaktivt stof og fremgangsmåde til fremstilling heraf
MXPA06002530A (es) Forma de dosificacion oral, en forma de multiples particulas, formulada mediante fusion.
US5405838A (en) Topical powder compositions containing a cyclic AMP derivative
ES2021673B3 (es) Procedimiento para preparar unos granulos de celiprololhidrocloridos en forma de comprimidos de excipientes
JPH08175996A (ja) ニコランジル安定化固形製剤の製法
JPS54154729A (en) Aminobenzoic acid derivative and drug preparation containing the same

Legal Events

Date Code Title Description
AN Processing applications according to articles 230 and 231 of law 9279/96: notification of filing an application
HHFK Processing applications according to articles 230 and 231 of law 9.279/96: republication
MT Patent procedure suspended until requirement met - articles 230 and 231 of law 9279/96
FGAN Processing applications according to articles 230 and 231 of law 9.279/96: granting
NB Patent issued - articles 230 and 231 of law 9279/96